ASNC-ACC-Letter-to-Congress_Price-Transparency-Legislation_02-01-2024
In February 2024, ASNC and the American College of Cardiology shared with Senate leaders concerns about the implications of Section 4 of S.3458, the Health Care PRICE Transparency Act 2.0, which posed an unnecessary administrative burden on already strained physician practices and would not have resulted in a patient-centric solution to price transparency. Section 4 would likely have impacted the vast majority of physicians, ranging from small family practices to specialists—all of whom provide imaging services in the office setting.
Resource Type
Health Policy Memos
Related Resources
PET Case: Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA)
Case summary: This case illustrates the role of multimodality imaging in diagnosing…
PET Case: A Case of Pacemaker Lead Infection in Patient with S. Lugdunensis Bacteremia
Case summary: 64-year-old female with history of CRT-D implantation admitted with acute…
ASNC Comments to CMS on 2026 Medicare Physician Fee Schedule Proposed Rule
ASNC_Comments-to-CMS-on_CY2026-MPFS-Proposed-Rule_1832_09-12-2025_FINAL